Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 96NIH 11NETWORK 5INDUSTRY 3FED 2UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1Breast 1

Conditions

Precancerous Conditions 1Neoplasm Metastasis 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Carboplatin 273Paclitaxel 267Gemcitabine 244Bevacizumab 226Cisplatin 218pembrolizumab 214Docetaxel 210Pemetrexed 162Capecitabine 148Fluorouracil 129Oxaliplatin 121Cyclophosphamide 121Nivolumab 112Dexamethasone 100Trastuzumab 89Leucovorin 87Cetuximab 85Rituximab 83Irinotecan 82Injections 81Erlotinib Hydrochloride 70Prednisone 68Doxorubicin 68Temozolomide 67atezolizumab 65Bortezomib 65Ipilimumab 64Fulvestrant 59Radiotherapy 54Drug Therapy 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × Celecoxib × Clear all
NCT00038103 2010-02-25

Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen

Pfizer

Phase 2 Completed
111 enrolled 14 charts
Breast

Breast Neoplasms

NCT00036283 2008-09-29

Chemoprevention of Oral Premalignant Lesions

Pfizer

Phase 2 Completed
42 enrolled
Other neoplasm

Precancerous Conditions

NCT00037180 2008-09-29

For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

Pfizer

Phase 2 Terminated
212 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡